nameofissuer,titleofclass,cusip,value,sshprnamt,sshprnamttype,investmentdiscretion,sole,shared,none,cik,reportcalendarorquarter,submissiontype,isamendment,filer,signaturedate,ticker
Acceleron Pharma Inc.,COM,00434H108,4004,42030,SH,SOLE,42030,0,0,0001645157,06-30-2020,13F-HR,false,"Foresite Capital Management III, LLC",08-13-2020,XLRN
Blueprint Medicines Corporation,COM,09627Y109,19469,249598,SH,SOLE,249598,0,0,0001645157,06-30-2020,13F-HR,false,"Foresite Capital Management III, LLC",08-13-2020,BPMC
"Cymabay Therapeutics, Inc.",COM,23257D103,5584,1599958,SH,SOLE,1599958,0,0,0001645157,06-30-2020,13F-HR,false,"Foresite Capital Management III, LLC",08-13-2020,CBAY
"Epizyme, Inc.",COM,29428V104,16032,998278,SH,SOLE,998278,0,0,0001645157,06-30-2020,13F-HR,false,"Foresite Capital Management III, LLC",08-13-2020,EPZM
"FibroGen, Inc.",COM,31572Q808,1621,40000,SH,SOLE,40000,0,0,0001645157,06-30-2020,13F-HR,false,"Foresite Capital Management III, LLC",08-13-2020,FGEN
"Myokardia, Inc.",COM,62857M105,38586,399360,SH,SOLE,399360,0,0,0001645157,06-30-2020,13F-HR,false,"Foresite Capital Management III, LLC",08-13-2020,MYOK
"Natera, Inc.",COM,632307104,10409,208768,SH,SOLE,208768,0,0,0001645157,06-30-2020,13F-HR,false,"Foresite Capital Management III, LLC",08-13-2020,NTRA
"Oric Pharmaceuticals, Inc.",COM,68622P109,16760,496893,SH,SOLE,496893,0,0,0001645157,06-30-2020,13F-HR,false,"Foresite Capital Management III, LLC",08-13-2020,ORIC
